DE STEFANO, ALFONSO
DE STEFANO, ALFONSO
Correlation between bevacizumab-related hypertension and response in mCRC patients
2010 DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models
2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
Double complete response in MCRC patient
2009 DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS
2009 M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer
2011 G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
2013 Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
2012 DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE
2012 Malapelle, Umberto; Bellevicine, Claudio; Salatiello, Maria; DE LUCA, Caterina; Rispo, Elisabetta; Riccio, Palmira; Sparano, Lucianna; DE STEFANO, Alfonso; Carlomagno, Chiara; Maiello, Franceso; Vita, Giulia; Nappi, Osar; Troncone, Giancarlo
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom?
2014 DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara
Surgery in lung cancer metastasis
2009 Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON
2014 Moretto, R; DE STEFANO, Alfonso; Carlomagno, Chiara
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools
2012 Raimondo, Lucia; Ferrara, IDA LUCIA; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; D'Armiento, FRANCESCO PAOLO; Ciancia, Giuseppe; Moretto, Roberto; Amalia De, Renzo; Carlomagno, Chiara
Bevacizumab as 4th line treatment in metastatic colorectal cancer
2009 L., Cannella; Carlomagno, Chiara; DE STEFANO, Alfonso; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors.
2010 Carlomagno, Chiara; Elide, Matano; Bianco, Roberto; Carolina, Cimminiello; Antonella, Prudente; Clorindo, Pagliarulo; Anna, Crispo; Lucia, Cannella; DE STEFANO, Alfonso; D'Armiento, FRANCESCO PAOLO; DE PLACIDO, Sabino
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients
2011 DE STEFANO, Alfonso; Carlomagno, Chiara; Stefano, Pepe; Bianco, Roberto; DE PLACIDO, Sabino
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients
2014 Della Vittoria Scarpati, Giuseppina; Calura, Enrica; Di Marino, Mariacristina; Romualdi, Chiara; Beltrame, Luca; Malapelle, Umberto; Troncone, Giancarlo; DE STEFANO, Alfonso; Pepe, Stefano; DE PLACIDO, Sabino; D’Incalci, Maurizio; Marchini, Sergio; Carlomagno, Chiara
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
2014 DE STEFANO, Alfonso; Carlomagno, Chiara
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.
2013 Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer
2009 DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; A., Crispo; S., Pepe; S., Alfieri; M., Colantuoni; Ac, Cella; L., Raimondo; DE PLACIDO, Sabino
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study
2009 Carlomagno, Chiara; Farella, A; Bucci, Luigi; D'Armiento, FRANCESCO PAOLO; Pesce, G; Pepe, S; Cannella, L; Pacelli, Roberto; DE STEFANO, Alfonso; Solla, R; D'Armiento, Maria; DE PLACIDO, Sabino
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Correlation between bevacizumab-related hypertension and response in mCRC patients | 1.5 Abstract in rivista | 2010 | DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino | |
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models | 1.5 Abstract in rivista | 2012 | Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino | |
Double complete response in MCRC patient | 1.5 Abstract in rivista | 2009 | DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino | |
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS | 1.5 Abstract in rivista | 2009 | M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino | |
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer | 1.5 Abstract in rivista | 2011 | G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe | |
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience | 1.1 Articolo in rivista | 2013 | Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara | |
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer | 1.1 Articolo in rivista | 2012 | DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano | |
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE | 1.1 Articolo in rivista | 2012 | Malapelle, Umberto; Bellevicine, Claudio; Salatiello, Maria; DE LUCA, Caterina; Rispo, Elisabetta; Riccio, Palmira; Sparano, Lucianna; DE STEFANO, Alfonso; Carlomagno, Chiara; Maiello, Franceso; Vita, Giulia; Nappi, Osar; Troncone, Giancarlo | |
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara | |
Surgery in lung cancer metastasis | 1.5 Abstract in rivista | 2009 | Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino | |
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON | 1.1 Articolo in rivista | 2014 | Moretto, R; DE STEFANO, Alfonso; Carlomagno, Chiara | |
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools | 1.1 Articolo in rivista | 2012 | Raimondo, Lucia; Ferrara, IDA LUCIA; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; D'Armiento, FRANCESCO PAOLO; Ciancia, Giuseppe; Moretto, Roberto; Amalia De, Renzo; Carlomagno, Chiara | |
Bevacizumab as 4th line treatment in metastatic colorectal cancer | 1.5 Abstract in rivista | 2009 | L., Cannella; Carlomagno, Chiara; DE STEFANO, Alfonso; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino | |
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. | 1.1 Articolo in rivista | 2010 | Carlomagno, Chiara; Elide, Matano; Bianco, Roberto; Carolina, Cimminiello; Antonella, Prudente; Clorindo, Pagliarulo; Anna, Crispo; Lucia, Cannella; DE STEFANO, Alfonso; D'Armiento, FRANCESCO PAOLO; DE PLACIDO, Sabino | |
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients | 1.1 Articolo in rivista | 2011 | DE STEFANO, Alfonso; Carlomagno, Chiara; Stefano, Pepe; Bianco, Roberto; DE PLACIDO, Sabino | |
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients | 1.1 Articolo in rivista | 2014 | Della Vittoria Scarpati, Giuseppina; Calura, Enrica; Di Marino, Mariacristina; Romualdi, Chiara; Beltrame, Luca; Malapelle, Umberto; Troncone, Giancarlo; DE STEFANO, Alfonso; Pepe, Stefano; DE PLACIDO, Sabino; D’Incalci, Maurizio; Marchini, Sergio; Carlomagno, Chiara | |
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Carlomagno, Chiara | |
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. | 1.1 Articolo in rivista | 2013 | Malapelle, Umberto; Bellevicine, Claudio; DE LUCA, Caterina; Salatiello, M; DE STEFANO, Alfonso; Rocco, D; de Rosa, N; Vitiello, F; Russo, S; Pepe, F; Iaccarino, A; Micheli, P; Illiano, A; Carlomagno, Chiara; Piantedosi, Fv; Troncone, Giancarlo | |
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer | 1.5 Abstract in rivista | 2009 | DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; A., Crispo; S., Pepe; S., Alfieri; M., Colantuoni; Ac, Cella; L., Raimondo; DE PLACIDO, Sabino | |
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study | 1.1 Articolo in rivista | 2009 | Carlomagno, Chiara; Farella, A; Bucci, Luigi; D'Armiento, FRANCESCO PAOLO; Pesce, G; Pepe, S; Cannella, L; Pacelli, Roberto; DE STEFANO, Alfonso; Solla, R; D'Armiento, Maria; DE PLACIDO, Sabino |